HANGZHOU, CHINA – June 2026 – Hangzhou Singclean Medical Products Co., Ltd., a global leader in the research and development of absorbable biomaterials, is pleased to announce its participation in the upcoming WHX Miami 2026, the premier healthcare trade event in the Americas. The exhibition will take place from June 17-19, 2026, at the Miami Beach Convention Center, where Singclean will be showcasing its innovative portfolio at Booth F44.

WHX Miami, formerly known as FIME, is the largest medical trade exhibition in the United States, serving as a critical gateway to the dynamic and rapidly growing healthcare markets of North and Latin America . The event is expected to draw over 12,000 professional visitors and more than 1,300 exhibitors from across the globe, solidifying its status as an unrivalled platform for industry leaders to forge partnerships, discover transformative solutions, and accelerate healthcare advancement . Singclean’s presence at WHX Miami underscores its strategic commitment to expanding its footprint in the Americas, a region recognized for its significant opportunities in the medical aesthetics and medical device sectors .

At this year’s expo, Singclean Medical will highlight its integrated approach to innovation, focusing on its high-end medical biomaterials and the rapidly growing field of regenerative aesthetics. The company will showcase its comprehensive portfolio of dermal fillers, which have garnered international acclaim for their safety, efficacy, and natural-looking results.

A key highlight will be the Singderm® line of hyaluronic acid (HA) dermal fillers. Singderm® is a sterile, viscoelastic gel containing 24mg/mL of cross-linked HA and 0.3% lidocaine for a more comfortable patient experience. Designed for mid-to-deep facial implantation, it is specifically indicated for the correction of moderate to severe facial wrinkles and folds, as well as lip definition, lasting more than 12 months.

Building on its successful participation in prior years, Singclean is particularly excited to introduce its latest advancements in regenerative aesthetics to the Americas market . Products on display will include the Singderm® PLLA Filler for collagen stimulation, the Singderm® Dual CaHA Filler for immediate lift and long-term biostimulation, and the SKformula® PDRN Skin Booster for advanced skin rejuvenation . This focus on next-generation technologies aligns with WHX Miami 2026’s emphasis on wellness, recovery, and performance-driven lifestyles .

"Engaging with the Americas market is a cornerstone of our global strategy, and WHX Miami provides the ideal venue for us to deepen those connections,” said a spokesperson for Singclean Medical. "We are eager to demonstrate how our cutting-edge, clinically-proven solutions for aesthetic treatment and surgical care can meet the evolving needs of healthcare practitioners and their patients in this key region. Our portfolio, validated by rigorous international certifications including CE and ANVISA, underscores our commitment to delivering the highest standards of quality and safety."

Singclean’s participation is further supported by its robust manufacturing capabilities, including a 28,000-square-meter international intelligent manufacturing base and a dedicated R&D team of over 100 talents. The company invests over 10% of its annual revenue into research and development, fostering partnerships with top-tier universities like Zhejiang University to drive continuous innovation in absorbable biomaterials. With more than 330 global strategic partners and products registered in over 50 countries, Singclean Medical is well-positioned to be the leading manufacturer of absorbable biomaterials in the world.

Singclean Medical invites all attendees, distributors, and healthcare professionals to visit Booth F44 at WHX Miami 2026 to explore their full range of aesthetic, orthopedic, and hemostatic solutions and to discuss potential collaborations.

About Hangzhou Singclean Medical Products Co., Ltd.

Established in 2003, Singclean Medical is devoted to providing diversified medical innovation solutions based on the research and development of absorbable biomaterials like hyaluronic acid and collagen. With a mission to improve the quality of healthcare globally, the company’s extensive product portfolio includes aesthetic treatments, medical sodium hyaluronate gel, absorbable hemostats, and IVD rapid tests.